Delgocitinib has emerged as a promising treatment for CHE, addressing unmet needs and enhancing understanding of this complex condition, notes Raj Chovatiya, MD, PhD, MSCI.

While some UI departments might not feel the full brunt of the strain yet, faculty and graduate students say it’s getting harder to balance the work.

I have always wondered if professors are checking what their previous students say about them on public forums. When they can’t sleep at night, do they stay up and stare at their deficient ...